Using Therapeutic Peptides to Treat Permanent Hypoparathyroidism with Mark Sumeray MD Amolyt Pharma TRANSCRIPT
Download PDFDec 27, 2022
Dr. Mark Sumeray is the Chief Medical Officer of Amolyt Pharma, focusing on rare diseases that affect the endocrine system, the hormonal system that regulates essential body functions. Despite the surgeon's best efforts, the parathyroid glands may be damaged or removed when operating on the thyroid gland creating...
Dec 27, 2022
Dr. Mark Sumeray is the Chief Medical Officer of Amolyt Pharma, focusing on rare diseases that affect the endocrine system, the hormonal system that regulates essential body functions. Despite the surgeon's best efforts, the parathyroid glands may be damaged or removed when operating on the thyroid gland creating...
Developing Antibacterial Peptide to Treat Periprosthetic Joint Infection with Dr. David Huang Peptilogics TRANSCRIPT
Download PDFDec 19, 2022
Dr. David Huang is Senior VP and Chief Medical Officer at Peptilogics and working to change the approach for treating and reducing reinfection rates of periprosthetic joint infection, PJI. Their lead highly charged peptide PLG0206 has been shown to be broad spectrum and active against multi-drug resistant bacteria,...
Dec 19, 2022
Dr. David Huang is Senior VP and Chief Medical Officer at Peptilogics and working to change the approach for treating and reducing reinfection rates of periprosthetic joint infection, PJI. Their lead highly charged peptide PLG0206 has been shown to be broad spectrum and active against multi-drug resistant bacteria,...